| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | Ausblick | IR-Daten | Anleihen | handeln |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -2,88% |
| AstraZeneca plc | 2 | 4 | 5 | 28,19 £ | +8,51% |
| BASF | 17 | 9 | 1 | 70,58 € | +24,28% |
| Bayer | 15 | 12 | 0 | 61,22 € | +19,78% |
| BB Biotech AG | 5 | 0 | 1 | 70,67 € | +6,91% |
| Biotest AG Vz. | 0 | 3 | 0 | 47,67 € | +21,45% |
| Bristol-Myers Squibb Co. | 2 | 1 | 0 | 35,33 $ | +5,49% |
| Eli Lilly and Co. | 1 | 3 | 0 | 38,25 $ | -6,71% |
| Gilead Sciences Inc. | 10 | 1 | 0 | 58,80 $ | +16,18% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,66% |
| H&R AG | 3 | 2 | 0 | 17,60 € | +19,48% |
| Johnson & Johnson | 5 | 4 | 0 | 71,80 $ | +15,47% |
| LANXESS AG | 14 | 6 | 1 | 70,60 € | +31,54% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +2,97% |
| Merck KGaA | 4 | 17 | 1 | 81,56 € | +9,80% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +11,97% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +7,66% |
| Roche Holding AG (Inhaberaktie) | 10 | 5 | 0 | 169,00 | +5,63% |
| Sanofi S.A. | 13 | 8 | 2 | 58,80 € | +7,89% |
| STADA Arzneimittel AG (vink. NA) | 9 | 9 | 1 | 25,99 € | +9,48% |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Wacker Chemie AG | 4 | 8 | 8 | 73,33 € | +31,49% |